Heart-type fatty acid binding protein as an early marker for myocardial infarction: Systematic review and meta-analysis

Emergency Medicine Journal

Volumn 30, Issue 4, 2013, Pages 280-286

  Carroll, Christopher ^a   Khalaf, Mohamad Al ^a   Stevens, John W ^a   Leaviss, Joanna ^a   Goodacre, Steve ^a   Collinson, Paul O ^b   Wang, Jenny ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; TROPONIN;

ACUTE CORONARY SYNDROME; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HEART INFARCTION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; HUMANS; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY;

EID: 84884213758     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emermed-2012-201174     Document Type: Article

References (42)

1. Goodacre S, Cross E, Arnold J, et al. The health care burden of acute chest pain. Heart 2005;91:229-30.
2. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
3. Cooper A, Calvert N, Skinner J, et al. Chest Pain Of Recent Onset: Assessment And Diagnosis Of Recent Onset Chest Pain Or Discomfort Of Suspected Cardiac Origin, Clinical Guideline 95. London: National Clinical Guideline Centre for Acute and Chronic Conditions, 2010.
4. Goodacre S, Bradburn M, Cross E, et al. The RATPAC (randomised assessment of treatment using panel assay of cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol Assess 2011;15:1-65.
5. Centre for Review and Dissemination. CRD's Guidance for Undertaking Reviews in Health Care. York: University of York, 2008.
6. Macaskill P, Gatsonis C, Deeks JJ, et al. Chapter 10: analysing and presenting results. In: Deeks JJ, Bossuyt PM, Gatsonis C, eds. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. http://srdta.cochrane.org/
7. Goodacre S. Cost-Effectiveness Of Diagnostic Strategies For Suspected Acute Coronary Syndrome (ACS). Project funded by the National Institute for Health Research Health Technology Assessment Programme. http://www.hta.ac.uk/ project/2269.asp (accessed 20 Jan 2012).
8. Whiting P, Rutjes A, Dinnes J, et al. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 2004;8:1-234.
9. Lunn DJ, Thomas A, Best N, et al. WinBUGSda Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2000;10:325-37.
10. Reitsma JB, Glas AS, Rutjes AWS, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005;58:982-90.
11. Brooks SP, Gelman A. Alternative methods for monitoring convergence of iterative simulations. J Computational Graphical Stat 1998;7:434-55.
12. Body R, McDowell H, Carley S, et al. A FABP-ulous 'rule out' strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. Resuscitation 2011;82:1041-6.
13. Cete YE. The value of point-of-care fatty acid binding protein in patients with chest pain in determining myocardial infarction in the emergency setting. Hong Kong J Emerg Med 2010;17:224-9.
14. Charpentier S, Ducasse JL, Cournot M, et al. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department. Acad Emerg Med 2010;17:27-35.
15. Di Serio F, Amodio G, Ruggieri E, et al. Proteomic approach to the diagnosis of acute coronary syndrome: preliminary results. Clin Chim Acta 2005;357:226-35.
16. Ecollan P, Collet JP, Boon G, et al. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay. Int J Cardiol 2007;119:349-54.
17. Garcia-Valdecasas S, Ruiz-Alvarez MJ, Garcia DT, et al. Diagnostic and prognostic value of heart-type fatty acid-binding protein in the early hours of acute myocardial infarction. Acta Cardiol 2011;66:315-21.
18. Haltern G, Peiniger S, Bufe A, et al. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. Am J Cardiol 2010;105:1-9.
19. Hjortshoj S, Kristensen SR, Ravkilde J. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med 2010;28:170-6.
20. Ilva T, Lund J, Porela P, et al. Early markers of myocardial injury: cTnI is enough. Clin Chim Acta 2009;400:82-5.
21. Lefevre GF. Multicenter evaluation of h-FABP semi-quantitative assay (cardio detect) in central laboratory: the point in acute myocardial infarction diagnosis. Ann Biol Clin (Paris) 2007;65:377-84.
22. Li C, Huang J. Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction. Acta Pharmacol Sin 2010;31:307-12.
23. Liao J, Chan CP, Cheung YC, et al. Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction. Int J Cardiol 2009;133:420-3.
24. Mad P, Domanovits H, Fazelnia C, et al. Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM 2007;100:203-10.
25. McCann CJ, Glover BM, Menown IB, et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008;29:2843-50.
26. Mion MM, Novello E, Altinier S, et al. Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology. Clin Biochem 2007;40:1245-51.
27. Naroo GYM. Elevated heart-type fatty acid-binding protein predicts early myocardial injury and aids in the diagnosis of non-ST elevation myocardial infarction. Hong Kong J Emerg Med 2009;16:141-7.
28. Valle HA, Riesgo LG, Bel MS, et al. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome. Eur J Emerg Med 2008;15:140-4.
29. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
30. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. New Engl J Med 2009;361:858-67.
31. Keller TZ. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. New Engl J Med 2009;361:868-77.
32. Aldous S, Pemberton C, Troughton R, et al. Heart fatty acid binding protein and myoglobin do not improve early rule out of acute myocardial infarction when highly sensitive troponin assays are used. Resuscitation 2012;83:e27-8.
33. Body R, Carley S. Reply to letter: still FABP-ulous even with a more sensitive troponin assay. Resuscitation 2012;83:e29-30.
34. Bruins Slot MHE, Reitsma JB, Rutten FH, et al. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: a systematic review and meta-analysis. Heart 2010;96:1957-63.
35. Chen L, Guo X, Yang F, et al. Role of heart-type fatty acid binding protein in early detection of acute myocardial infarction in comparison with cTnI, CK-MB and myoglobin. J Huazhong Univ Sci Technolog Med Sci 2004;24:449-51.
36. Haastrup B, Gill S, Kristensen SR, et al. Biochemical markers of ischaemia for the early identification of acute myocardial infarction without ST segment elevation. Cardiology 2000;94:254-61.
37. Ishii J, Wang JH, Naruse H, et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997;43:1372-8.
38. Okamoto F, Sohmiya K, Ohkaru Y, et al. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000;38:231-8.
39. Seino Y, Tomita Y, Takano T, et al. Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. Circ J 2004;68:144-8.
40. Seino Y, Ogata K, Takano T, et al. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 2003;115:185-90.
41. Alhashemi JA. Diagnostic accuracy of a bedside qualitative immunochromatographic test for acute myocardial infarction. Am J Emerg Med 2006;24:149-55.
42. Viswanathan K, Kilcullen N, Morrell C, et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol 2010;55:2590-8.